LEXARIA BIOSCIENCE CORP. (LEXX) Net margin 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1686.0%FY2025 · since FY2016: -3136.8% → -1686.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1686.0% | -437.7 pp |
| FY2024 | -1248.2% | +1698.1 pp |
| FY2023 | -2946.4% | -100.1 pp |
| FY2022 | -2846.3% | -2289.1 pp |
| FY2021 | -557.2% | +505.0 pp |
| FY2020 | -1062.2% | -2904.0 pp |
| FY2019 | 1841.8% | +318.5 pp |
| FY2018 | 1523.2% | +4555.1 pp |
| FY2017 | -3031.9% | +104.9 pp |
| FY2016 | -3136.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net incomeLEXX Gross profitLEXX Gross marginLEXX Operating incomeLEXX Operating marginLEXX Operating cash flowLEXX Free cash flowLEXX Capital expendituresLEXX Return on equityLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →